396 related articles for article (PubMed ID: 20441798)
1. Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics.
Cole DM; Beckmann CF; Long CJ; Matthews PM; Durcan MJ; Beaver JD
Neuroimage; 2010 Aug; 52(2):590-9. PubMed ID: 20441798
[TBL] [Abstract][Full Text] [Related]
2. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
4. Nicotine increases neural response to unpleasant stimuli and anxiety in non-smokers.
Kobiella A; Ulshöfer DE; Vollmert C; Vollstädt-Klein S; Bühler M; Esslinger C; Smolka MN
Addict Biol; 2011 Apr; 16(2):285-95. PubMed ID: 20731637
[TBL] [Abstract][Full Text] [Related]
5. Nicotine effects on brain function and functional connectivity in schizophrenia.
Jacobsen LK; D'Souza DC; Mencl WE; Pugh KR; Skudlarski P; Krystal JH
Biol Psychiatry; 2004 Apr; 55(8):850-8. PubMed ID: 15050867
[TBL] [Abstract][Full Text] [Related]
6. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
7. Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function.
Lerman C; Gu H; Loughead J; Ruparel K; Yang Y; Stein EA
JAMA Psychiatry; 2014 May; 71(5):523-30. PubMed ID: 24622915
[TBL] [Abstract][Full Text] [Related]
8. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
9. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers.
Demazières A; Luthringer R; Coppel E; Gilles C; Fleury C; Roegel JC; Delarue A; Laur C; Lagrue G
Addict Behav; 2006 Mar; 31(3):537-43. PubMed ID: 15964703
[TBL] [Abstract][Full Text] [Related]
10. Modafinil and nicotine interactions in abstinent smokers.
Sofuoglu M; Waters AJ; Mooney M
Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195
[TBL] [Abstract][Full Text] [Related]
11. Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.
Lesage E; Aronson SE; Sutherland MT; Ross TJ; Salmeron BJ; Stein EA
JAMA Psychiatry; 2017 Jun; 74(6):632-640. PubMed ID: 28403383
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity.
Ettinger U; Williams SC; Patel D; Michel TM; Nwaigwe A; Caceres A; Mehta MA; Anilkumar AP; Kumari V
Neuroimage; 2009 Apr; 45(2):549-61. PubMed ID: 19159693
[TBL] [Abstract][Full Text] [Related]
13. Abnormal functional connectivity of hippocampus during episodic memory retrieval processing network in amnestic mild cognitive impairment.
Bai F; Zhang Z; Watson DR; Yu H; Shi Y; Yuan Y; Zang Y; Zhu C; Qian Y
Biol Psychiatry; 2009 Jun; 65(11):951-8. PubMed ID: 19028382
[TBL] [Abstract][Full Text] [Related]
14. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers.
Sofuoglu M; Babb D; Hatsukami DK
Nicotine Tob Res; 2003 Dec; 5(6):947-53. PubMed ID: 14668079
[TBL] [Abstract][Full Text] [Related]
15. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study.
McBride D; Barrett SP; Kelly JT; Aw A; Dagher A
Neuropsychopharmacology; 2006 Dec; 31(12):2728-38. PubMed ID: 16598192
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging studies of cigarette smoking.
Azizian A; Monterosso J; O'Neill J; London ED
Handb Exp Pharmacol; 2009; (192):113-43. PubMed ID: 19184648
[TBL] [Abstract][Full Text] [Related]
17. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder.
Etkin A; Prater KE; Schatzberg AF; Menon V; Greicius MD
Arch Gen Psychiatry; 2009 Dec; 66(12):1361-72. PubMed ID: 19996041
[TBL] [Abstract][Full Text] [Related]
18. The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.
Beaver JD; Long CJ; Cole DM; Durcan MJ; Bannon LC; Mishra RG; Matthews PM
Neuropsychopharmacology; 2011 Aug; 36(9):1792-800. PubMed ID: 21544072
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers.
Harakas P; Foulds J
Psychopharmacology (Berl); 2002 May; 161(3):271-7. PubMed ID: 12021830
[TBL] [Abstract][Full Text] [Related]
20. Changes in resting state functional brain connectivity and withdrawal symptoms are associated with acute electronic cigarette use.
Hobkirk AL; Nichols TT; Foulds J; Yingst JM; Veldheer S; Hrabovsky S; Richie J; Eissenberg T; Wilson SJ
Brain Res Bull; 2018 Apr; 138():56-63. PubMed ID: 28528203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]